NIMG-06. KINETICS-BASED RESPONSE METRIC DISCRIMINATE IMPROVED OUTCOMES FOR PATIENTS RECEIVING BEVACIZUMAB-BASED THERAPIES

INTRODUCTION: Evaluating treatment response in glioblastoma is a difficult task for clinicians, particularly in recurrent disease. Current response metrics focus on changes in imageable tumor burden which can be ambiguously affected by anti-angiogenic therapy. In previous work, we reported the abili...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Singleton, Kyle, Kirby, Destiney, Johnston, Sandra, Rickertsen, Cassandra, De Leon, Gustavo, Whitmire, Scott, Clark-Swanson, Kamala, Morris, Yvette, Bendok, Bernard, Mrugala, Maciej, Porter, Alyx, Swanson, Kristin
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217281/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.734
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares